Shire plc (SHPG)
-NasdaqGS 96.94 
1.66(1.74%) May 21, 4:00PM EDT|After Hours
:
97.01 0.07 (0.07%) May 21, 5:58PM EDT
| Prev Close: | 95.28 |
|---|
| Open: | 95.53 |
|---|
| Bid: | N/A |
|---|
| Ask: | 156.00 x 100 |
|---|
| 1y Target Est: | 106.71 |
|---|
| Beta: | 0.64 |
|---|
| Next Earnings Date: | N/A |
|---|
| Day's Range: | 95.42 - 97.24 |
|---|
| 52wk Range: | 80.09 - 102.04 |
|---|
| Volume: | 946,841 |
|---|
| Avg Vol (3m): | 590,624 |
|---|
| Market Cap: | 17.82B |
|---|
| P/E (ttm): | 31.68 |
|---|
| EPS (ttm): | 3.06 |
|---|
| Div & Yield: | 0.88 (0.90%) |
|---|
The broker you select will become the default broker for Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.
Headlines
- The Surprising Link Between ADHD and Obesityat Motley Fool(Tue, May 21)
- SHIRE PLC Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Tue, May 21)
- Shire Rises On Unusually High Volume (SHPG)at TheStreet(Mon, May 20)
- 5 Drugs Stocks On The Riseat TheStreet(Mon, May 20)
- Shire advances after report renews takeover speculationat theflyonthewall.com(Mon, May 20)
- Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic DiseasesPR Newswire(Mon, May 20)
- Leerink estimates Shire takeout value at least $110 per shareat theflyonthewall.com(Mon, May 20)
- Shire may return cash to thwart takeover, Daily Mail reportstheflyonthewall.com(Mon, May 20)
- Shire to Present Scientific Data Across a Range of Psychiatric Disorders at American Psychiatric Association Annual MeetingPR Newswire(Fri, May 17)
- SHIRE PLC Files SEC form 8-K, Financial Statements and ExhibitsEDGAR Online(Thu, May 16)
- Is AstraZeneca Gearing Up for a Shopping Spree?at Motley Fool(Wed, May 15)
- Position Yourself For Big Returns In The Stem Cell Space: Jason Kolbertat Seeking Alpha(Mon, May 13)
- Shire's New Rare Disease Deal: Interesting Science Meets Unique Financingat Seeking Alpha(Mon, May 13)
- SHIRE PLC FinancialsEDGAR Online Financials(Sat, May 11)
- SHIRE PLC FinancialsEDGAR Online Financials(Sat, May 11)
Key Statistics
| Forward P/E (1 yr): | 13.17 |
|---|
| P/S (ttm): | 3.75 |
|---|
| Ex-Dividend Date: | 06-Mar-13 |
|---|
Analysts
| Annual EPS Est
(Dec-13)
: | 6.65 |
|---|
| Quarterly EPS Est
(Jun-13)
: | 1.64 |
|---|
| Mean Recommendation*: | 1.9 |
|---|
| PEG Ratio (5 yr expected): | 1.46 |
|---|
Business Summary
Shire plc, a specialty biopharmaceutical company, engages in the research and development, manufacture, sale, and distribution of pharmaceutical products.
View More